[Federal Register Volume 61, Number 77 (Friday, April 19, 1996)]
[Notices]
[Page 17322]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-9723]



-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on December 22, 1995, Knoll 
Pharmaceuticals, 30 North Jefferson Road, Whippany, New Jersey 07981, 
made application, which was received for processing on March 13, 1996, 
to the Drug Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the Schedule II controlled substance hydromorphone 
(9150).
    The firm plans to produce hydromorphone bulk product and finished 
dosage units of dilaudid for distribution to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than June 18, 1996.

    Dated: April 9, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 96-9723 Filed 4-18 -96; 8:45 am]
BILLING CODE 4410-09-M